Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma (Vitilimel Study)

NCT04920162 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT04920162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma (Vitilimel Study)
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Not applicable
Overall status
Completed
Start date
December 28, 2021
Completion date
April 5, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma and vitiligo